These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3265522)

  • 41. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 42. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
    Stoof JC; Kebabian JW
    Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
    [No Abstract]   [Full Text] [Related]  

  • 47. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.
    Walters JR; Bergstrom DA; Carlson JH; Chase TN; Braun AR
    Science; 1987 May; 236(4802):719-22. PubMed ID: 2953072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ
    Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
    Lublin H; Gerlach J
    Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
    Mattingly BA; Rowlett JK; Lovell G
    Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat.
    Fletcher GH; Starr MS
    Neuroscience; 1989; 28(1):171-80. PubMed ID: 2569694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1989 Mar; 162(2):237-44. PubMed ID: 2566498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB; Jackson DM; Wallis EM; Edwards SR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L; Longoni R; Mulas A; Di Chiara G
    Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.